Global Stem Cell Therapy for Osteoarthritis Pipeline Analysis Report 2017

The global osteoarthritis market is expected to grow at a CAGR of 8.55% over the period of 2014-2019.

The stem cell therapy for osteoarthritis pipeline analysis report includes ongoing clinical and non-clinical trends in the global stem cell therapy for osteoarthritis. Majority of the pipeline therapeutics are in early stages of development. There is no cure for the disease, but treatments are available to manage the symptoms. A long-lasting and less-frequent dose can impact overall osteoarthritis market.

The expected growth is because of increasing awareness of osteoarthritis and increasing diagnosis rates, rising older population, and increasing cases of obesity. Osteoarthritis is directly related to obesity, with approximately 37% of osteoarthritis patients suffering from obesity.

Major companies

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: STEM CELL THERAPY FOR OSTEOARTHRITIS: AN INSIGHT

PART 05: MAJOR REGULATORY AUTHORITIES

PART 06: PIPELINE LANDSCAPE

PART 07: COMPARATIVE ANALYSIS

PART 08: INDICATION ANALYSIS

PART 09: THERAPEUTIC ASSESSMENT BY THERAPY

PART 10: THERAPEUTIC ASSESSMENT BY ROA

PART 11: THERAPEUTIC ASSESSMENT BY STAGE AND ROA

PART 12: KEY COMPANIES

For more information about this report visit https://www.researchandmarkets.com/research/fsvz6c/stem_cell_therapy

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716